4.1. Circuit-based evidence of neuromodulation for OCD
Previous original and review studies highlight five neural circuits correlating with particular OCD characteristics and their evolution 15 22 . While OCD is commonly linked to dysfunctional cortico-striato-thalamo-cortical (CSTC) circuits, changes in structures beyond these circuits also contribute to the underlying pathology. Therefore, the classification method chosen in this article provides a more detailed correlation between symptoms, structures, and circuits, which can potentially shed light on the future neuromodulation strategies for OCD.
4.1.1. Fronto-limbic circuit
The fronto-limbic circuit plays a role in generating emotional responses and evaluates whether those responses are appropriate or require regulation, and it is connected with the hippocampus and regions from other circuits that are involved in top-down behavioral control 23 24. The key nodes in this circuit which is also involved with OCD neuromodulation is ALIC. In our included studies, only three studies targeted this neurocircuit, and all of them were ALIC/BNST-DBS (invasive) studies, with total of 25 OCD patients enrolled, yet they demonstrated the most effective YBOCS improvement outcomes among all the circuits studied 25-27. Cognitive behavioral therapy for OCD also appears to modulate fronto-limbic dysfunction via exposure and response prevention 28. There are other structures that are also classified as part of the fronto-limbic circuit, including amygdala and ventromedial prefrontal cortex, yet larger amount of data is needed to prove the superiority of modulating the fronto-limbic network.
4.1.2. Dorsal cognitive circuit
In OCD, the dorsal cognitive circuit plays a crucial role in impairments related to goal-directed behaviors, including working memory and the ability to exert top-down control over emotional responses 22 29 30. The preSMA and DLPFC are key structures in this circuit targeted for neuromodulation. Our review included thirteen studies focusing on this circuit, with nine employing TMS to stimulate the DLPFC and four targeting the preSMA. The studies varied, targeting the right DLPFC, left DLPFC, or both sides 31-42. The question of laterality in TMS treatment for OCD is actively debated. Evidence indicates that low-frequency stimulation of the right DLPFC and high-frequency bilateral stimulation of the DLPFC might be beneficial. One study noted modest, lateralized effects on OCD symptoms with 1 Hz rTMS directed at the right DLPFC, hinting at a possible preference for targeting the right hemisphere in certain cases 43. Nevertheless, our meta-analysis did not show a definitive preference for laterality.
4.1.3. Sensorimotor circuit
The sensorimotor circuit, encompassing both cortical and subcortical areas, is crucial for the initiation and regulation of motor actions and the integration of sensory inputs 22 44. This circuit is implicated in the distressing sensations or perceptions that prompt repetitive behaviors in OCD, as well as the excessive habit formation associated with certain compulsions. The supplementary motor area (SMA) is a primary node targeted for neuromodulation in OCD, typically through non-invasive methods like tDCS and rTMS. In our analysis, 131 patients treated within this circuit showed notable improvement, with an average decrease of nearly 3 points on the YBOCS, making it the second most effective circuit following the fronto-limbic circuit in terms of symptom reduction.
4.1.4. Ventral cognitive circuit
The ventral cognitive circuit is proposed to be fundamentally involved in response inhibition in OCD, which is the ability to withhold inappropriate behaviors 45. Response inhibition is mediated in part by STN, which is the key node for neuromodulation in this circuit, it plays a role in regulating emotional and motivational behaviors through its connections with fronto-limbic and ventral affective circuits 46 47. Only one study was included that utilized STN-DBS for treating OCD. In this study, patients experienced a median decrease in YBOCS scores from 30 to 19 However, improvements in anxiety were not observed, and side effects such as temporary anxiety, headaches, and post-operative dyskinesia were reported 47. While in our reported case, short term STN-DBS did not improve the patient’s OCD symptoms, but instead resulted to numbness and dizziness, and temporary anxiety, and according to the psychiatrist, the patient’s cognitive abilities also fluctuated along with her level of anxiety. Our result differed a little with the included study in terms of OCD symptoms but showed similar side effects such as anxiety. We hypothesize that these issues may be linked to the stimulation of different subregions of electrode placement, particularly the ventral contacts, potentially causing more severe psychiatric side effects.
4.1.5. Ventral affective circuit
Pathological ventral affective circuit changes in OCD may lead to altered reward responsiveness, which is the alterations in the ability to anticipate, and respond to rewards. The key nodes within this circuit are OFC and ventral striatum (particularly the NAcc), and the thalamus 22 48 49.
Our study reviewed fewer investigations focusing on this circuit compared to other neural circuits. We included seven studies in total; three of these studies used invasive DBS targeting the NAcc, while the other four employed non-invasive techniques like tDCS, cTBS, and TMS on the OFC. Studies using NAcc-DBS showed significant effectiveness, whereas those involving non-invasive methods on the OFC had notably lesser efficacy. The aspect of laterality also emerged as a significant theme, with two studies targeting the left OFC and one targeting the right OFC. There is evidence suggesting that tDCS on the left OFC may be more effective, a finding supported by Acevedo et al., who noted that positioning the cathode on the left OFC could enhance efficacy 50. In our reported case, using the bottom contacts to stimulate the NAcc led to temporary episodes of panic, depression, and anxiety, without notable improvements in OCD symptoms. Several studies have similarly reported that NAcc-DBS can trigger panic and anxiety. These findings suggest that DBS might have varying impacts on unconditioned and conditioned anxiety, which could depend on the specific area stimulated 51.
In summary, three out of the five circuits (sensorimotor, dorsal cognitive circuit, and ventral cognitive circuit) have garnered sufficient attention with an adequate number of studies to substantiate their impact on OCD symptoms. However, further validation is required for fronto-limbic circuit and ventral cognitive circuit. Overall, it is still too early to determine the best target circuit for OCD. Further high-level evidence studies, such as randomized controlled trials (RCTs), are needed at the circuitry level to determine the optimal option and further to explore the potential connectivity between targets.
In conclusion, the fronto-limbic circuit appears to be the most promising target for modulating OCD symptoms, particularly for individuals exhibiting compulsive and repetitive behaviors. This is supported by our case report, where stimulation of the ALIC provided the most significant symptom relief. Connectivity-derived models established by Li et al. predicted clinical improvements based on the overlap of stimulation with the identified tract. These models were validated across different patient cohorts targeting the ALIC, NAcc, and STN, further supporting our conclusion 21. However, it remains premature to definitively identify the best circuit to target for OCD treatment. More rigorous studies, such as randomized controlled trials (RCTs), are necessary at the circuit level to identify the most effective target and to further investigate the connectivity between potential targets.
4.2. Efficacy of invasive and noninvasive neuromodulation for OCD
In our study encompassing 27 reviews, we distinguished between six invasive and nineteen non-invasive neurostimulation techniques for OCD treatment, all showing notable efficacy in reducing symptoms according to YBOCS scale. Moreover, these interventions also significantly improved related psychological disorders such as anxiety and depression, as demonstrated by scores on the HAMA, HAMD, MDRS, and BDI.
Building on these findings, we highlight a pioneering case report where DBS was applied to a patient with treatment-resistant OCD, targeting two neural circuits for potential symptom alleviation. Our surgical strategy involved the precise placement of a quadripolar electrode to modulate the ventral affective and fronto-limbic circuit, specifically the Nacc within ventral affective circuit, and the fronto-limbic circuit via the ALIC. This intervention was pursued after traditional treatments, including pharmacological and cognitive behavioral therapies, had failed to produce satisfactory results.
The outcome of this DBS surgery was profound, offering significant symptomatic relief for the patient, a development thoroughly detailed in our study's Results section. Continuous follow-up assessments have documented a sustained improvement in the patient's OCD symptoms, underscoring the transformative potential of DBS for individuals with refractory OCD. This case report not only demonstrates the therapeutic promise of DBS but also opens new avenues for the application of neurostimulation techniques in the management of psychiatric disorders, warranting further research and exploration.
4.3. Safety of invasive and noninvasive neuromodulation for OCD
Based on all the included studies, 19 out of 27 studies reported no adverse events or side effects, two tDCS study reported transient headache and dizziness 52 53. One cTBS study reported increased anxiety 54. However, DBS manifested much more adverse events, mostly were non-permanent, including nausea, increase in depressive symptoms, and stimulation related adverse events, such as hypomanic symptoms headaches, taste reduction, etc. 55. Another DBS study targeting BNST showed severe adverse events, including suicide attempts, fractures, epileptic seizures, but none of which were life threatening or resulted in any permanent injury 26. In our proof-of-concept case report, we did not observe adverse events or side effects, which further proved the safety of this target. The patient responded to Nacc-DBS with transient mirthful laughter, consistent with findings in previous studies 56. This response may be attributed to the Nacc's role as a key node in the reward circuit, associated with feelings of pleasure and satisfaction. Additionally, as part of the ventral affective circuit, the Nacc is interconnected with various limbic system components, including the amygdala and hippocampus, which regulate emotion and memory. Stimulation of the Nacc can thus modulate these connections, potentially influencing emotional processing and increasing susceptibility to laughter 57-59.
4.4. Future perspectives of neuromodulation for OCD
Invasive and non-invasive treatments, despite their differing methodologies, fundamentally aim to modulate various circuits within the brain. While different treatments targeting these circuits can offer therapeutic benefits, the extent of their effectiveness varies significantly among individuals due to unique biological differences.
Future research could pivot towards closed-loop control strategies, using personalized monitoring to accurately assess a patient's circuit status and applying closed-loop stimulation based on this data 60. This approach, by adjusting to real-time physiological feedback, promises more targeted and effective treatments.
In conclusion, both invasive and noninvasive neuromodulation are effective in treating OCD and its comorbid depression and anxiety symptoms. Stimulating fronto-limbic, sensorimotor, ventral affective, and dorsal cognitive circuits all have significant effects in improving OCD symptoms, despite potential limitations due to small sample sizes included, modulating the fronto-limbic circuit seems to be linked with the best outcomes for improving OCD symptoms. We applied evidence-based clinical practice and found out that ALIC, as one of the nodes within the fronto-limbic circuit, was the optimal DBS target for the individual OCD patient, corroborating our previous findings. Further studies with higher levels of evidence and larger cohorts are needed, with more tailored neurostimulation methods for individual patients that lay the foundation of the future closed-loop DBS.